title: Effect of phosphatidylethanolamine on the properties of phospholipid-apolipoprotein complexes.
abstract: Plasma high density lipoproteins (HDL) are synthesized in intestinal mucosal cells and hepatocytes and are secreted into the blood. Factors influencing the structure and function of these HDL, such as lipid and protein composition, are poorly understood. It appears, however, that intracellular, discoidal HDL are enriched, relative to plasma HDL, in phosphatidylethanolamine (PE), a phospholipid known to generate unusual, nonbilayer structures of putative physiological significance. Although incubation of dimyristoylphosphatidylcholine (DMPC) with apolipoprotein A-I at the gel-liquid crystalline phase transition temperature results in the spontaneous formation of lipid-protein complexes, the presence of proportionately small amounts of PE prevents the formation of such complexes, suggesting that PE profoundly alters the phase properties of the phospholipid bilayers. However, by using a detergent-mediated method for the formation of PE-rich model nascent HDL from phospholipids and apolipoprotein A-I, lipid-protein complexes containing as much as 75% DLPE could be formed, thus demonstrating that the presence of PE causes a kinetic, rather than a thermodynamic, barrier to spontaneous complex formation. The products contained a DLPE:DMPC molar ratio similar to that of the initial incubation mixture; however, as the mole percentage of DLPE increased, the products became less heterogeneous, the buoyant density of the products increased, and the Stokes diameter of the products decreased. Similar results were obtained when dimyristoylphosphatidylethanolamine (DMPE) and dipalmitoylphosphatidylethanolamine (DPPE) were employed in lieu of DLPE. Electron microscopy of complexes containing DLPE and DMPC at a 1:1 molar ratio showed that these particles possessed a discoidal, bilayer morphology similar to that seen with complexes containing only phosphatidylcholine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Biological Chemistry, Hahnemann University, Philadelphia, Pennsylvania 19102.
authors.forename: E A
authors.initials: EA
authors.lastname: Bonomo
authors.forename: J B
authors.initials: JB
authors.lastname: Swaney
mesh_terms: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A / Q000378:metabolism / Q000648:ultrastructure*; D008076:Cholesterol, HDL / Q000097:blood / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D006801:Humans; D008297:Male; D010714:Phosphatidylethanolamines / Q000494:pharmacology*; D014461:Ultracentrifugation
chemical_list: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D008076:Cholesterol, HDL; D010714:Phosphatidylethanolamines; C007445:1,2-dilauroylphosphatidylethanolamine